. 2015 Feb 12;36(2):149–173. doi: 10.1210/er.2014-1063

Table 1.

Prevalence of Obesity in Adult Populations Living at or Above 1500 m

First Author, Year (Ref)	Population	Altitude, m	n	Age, y	Diagnosis Criteria	BMI, kg/m²	Crude Prevalence, %	Age- Adjusted Prevalence, %
Chen, 2011 (221)	Lhasa, Tibet, China	3658–4200	1289	≥18	N.A.	>28	16.7
Malaga, 2010 (216)	Lari, Peru	3600	74	>18	N.A.	≥30	8.7
Medina, 2006 (215)	Arequipa, Peru	2390^a	1878	20–80	WHO, 2000	≥30		17.6
Mohanna, 2006 (217)	San Pedro de Cajas, Peru	4100	102	≥30	ATP III, 2002	≥30	10.8
Negi, 2012 (220)	Spiti Valley, India	3900	242	≥20	Consensus, India	≥25	17.4
	Spiti Valley, India	3100	171	≥20	Consensus, India	≥25	35.7
Pajuelo-Ramirez, 2010 (50)	Peru	≥3000	959	≥20	WHO, 1997	≥30	8.5
	Peru	1000–2999	808	≥20	WHO, 1997	≥30	11
	Peru	<1000	2425	≥20	WHO, 1997	≥30	17.5
Schargrodsky, 2008 (219)	Quito, Ecuador	2800	1638	25–64	ATP III, 2002	≥30		16.3
	Bogota, Colombia	2625	1553	25–64	ATP III, 2002	≥30		18
	Mexico City, Mexico	2240	1722	25–64	ATP III, 2002	≥30		31
	Barquisimeto, Venezuela	564	1848	25–64	ATP III, 2002	≥30		25.1
	Santiago, Chile	520	1655	25–64	ATP III, 2002	≥30		26.6
	Lima, Peru	153	1652	25–64	ATP III, 2002	≥30		22.3
	Buenos Aires, Argentina	10	1482	25–64	ATP III, 2002	≥30		19.7
Seclén, 1999 (207)	Huaraz, Peru	3052	77	>18	NIH-US, 1985	≥27	18.3
	Waiku, Amazon, Peru	600	54	>18	NIH-US, 1985	≥27	0
	Tarapoto, Amazon, Peru	333	90	>18	NIH-US, 1985	≥27	17
	Cuñumbuque, Amazon, Peru	300	101	>18	NIH-US, 1985	≥27	10.9
	Lima, Peru	123	158	>18	NIH-US, 1985	≥27	22.8
	Castilla, Peru	30	118	>18	NIH-US, 1985	≥27	36.7
Segura, 2006 (212)	Andes, Peru	3493^a	N.A.	>18	N.A.	≥30	9.1
	Andes, Peru	2351^a	N.A.	>18	N.A.	≥30	8.7
	Amazon, Peru	168.5^a	1630	>18	N.A.	≥30	11.7
	Coast, Peru	31.5^a	7725	>18	N.A.	≥30	13.5
Shah, 2004 (218)	Ghizer, Pakistan	1675–1980^b	4203	≥18	WHO, 2000	≥30	2.3
Sherpa, 2010 (213)	Lhasa, Tibet, China	3660	371	30–70	WHO, 2000	≥30	9.7
	Nepal	2900	119	30–70	WHO, 2000	≥30	11.8
	Nepal	1200	127	30–70	WHO, 2000	≥30	19.7
Woolcott, 2014 (208)	United States	<1500	N.A.	≥20	ATP II, 1998	≥30		30.6
	United States	≥1500	N.A.	≥20	ATP II, 1998	≥30		23.3

Abbreviations: ATP, Adult Treatment Panel; NIH-US, National Institutes of Health-United States; WHO, World Health Organization; N.A., information not available. Studies were selected on the basis that they were conducted in at least one representative population residing at or above 1500 m.

Median altitude of the cities sampled, using altitude values obtained online.

Altitude range is provided elsewhere (268).